drugset / Trial / NCT04372277
Taltz in Combination With Enstilar for Psoriasis
Phase 4
Recruiting
25 enrolled
Psoriasis Treatment Center of Central New Jersey
Eli Lilly and Company · collab
NaSingle-groupOpen-labelTreatment
Summary
Enstilar in combination with Taltz for plaque psoriasis.
Timeline
- Start
- 2020-04-28
- Primary completion
- 2021-03-01
- Completion
- 2021-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcipotriene | Other / unclassified | — | Topical |
| Subject | betamethasone dipropionate | Small molecule | — | Topical |